-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 1 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 2 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO
-
-
Mashup Score: 0Study Highlights Regional Variability in PBC Prevalence, Limited Specialist Care Access - 2 month(s) ago
Study findings highlight regional variability in the prevalence of PBC in the US in 2021, additionally suggesting potential barriers to specialist care.
Source: www.hcplive.comCategories: General Medicine NewsTweet-
The study found the adjusted prevalence of adult patients with #PBC in 2021 was 40.9 per 100,000 persons, with the greatest absolute number of patients with PBC observed in heavily populated urban areas. Learn more: https://t.co/0dOxIUKpMk https://t.co/TAjFGxqRL3
-
-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 3 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine NewsTweet-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO
-
-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 5 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO
-
-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 5 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO
-
-
Mashup Score: 0
The designation follows positive topline data from the phase 2a trial of CNP-104 in PBC, which were presented at AASLD’s The Liver Meeting
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
ICYMI: The FDA granted Orphan Drug Designation to @CourPharma’s CNP-104 for the treatment of #PBC. In a phase 2a trial, CNP-104 demonstrated favorable T cell response and slowed disease progression. Learn more: https://t.co/th8tVukXSq https://t.co/Pia61M5KnF
-
-
Mashup Score: 0Unlocking Treatment Possibilities in PBC - 7 month(s) ago
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Myalgia, Myopathy, and Rhabdomyolysis: Rhabdomyolysis resulting in acute kidney injury occurred in one IQIRVO-treated patient who had cirrhosis at baseline and was also taking a stable dose of an HMG-CoA reductase inhibitor
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO
-
-
Mashup Score: 1
The CRL is consistent with the outcome of a September Gastrointestinal Drugs Advisory Committee meeting.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
BREAKING: The US Food and Drug Administration has issued a Complete Response Letter to Intercept Pharmaceuticals’ obeticholic acid (Ocaliva) for the treatment of #PBC, denying to approve the supplemental New Drug Application in its current form. https://t.co/v9qGPLa4cV https://t.co/Nf39O08r7h
-
-
Mashup Score: 1
The CRL is consistent with the outcome of a September Gastrointestinal Drugs Advisory Committee meeting.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet-
BREAKING: The US Food and Drug Administration has issued a Complete Response Letter to Intercept Pharmaceuticals’ obeticholic acid (Ocaliva) for the treatment of #PBC, denying to approve the supplemental New Drug Application in its current form. https://t.co/v9qGPLa4cV https://t.co/Nf39O08r7h
-
Learn key aspects of #PBC relevant to patient management and historical treatment approaches. Watch the On-Demand Broadcast to hear experts discuss the phase 3 clinical trial and evaluate the safety and efficacy results. https://t.co/089ItaxcQk https://t.co/AduQmIbUiO